AAAAAA
Results: 1-25/50
Authors:
ERIKSSON M
HADELL K
HOLME I
WALLDIUS G
KJELLSTROM T
Citation: M. Eriksson et al., COMPLIANCE WITH AND EFFICACY OF TREATMENT WITH PRAVASTATIN AND CHOLESTYRAMINE - A RANDOMIZED STUDY ON LIPID-LOWERING IN PRIMARY-CARE, Journal of internal medicine, 243(5), 1998, pp. 373-380
Authors:
ANDERSSEN SA
HOLME I
URDAL P
HJERMANN I
Citation: Sa. Anderssen et al., ASSOCIATIONS BETWEEN CENTRAL OBESITY AND INDEXES OF HEMOSTATIC, CARBOHYDRATE AND LIPID-METABOLISM - RESULTS OF A 1-YEAR INTERVENTION FROM THE OSLO DIET AND EXERCISE STUDY, Scandinavian journal of medicine & science in sports, 8(2), 1998, pp. 109-115
EFFECTS OF DOXAZOSIN AND ATENOLOL ON ATHEROTHROMBOGENIC RISK PROFILE IN HYPERTENSIVE MIDDLE-AGED MEN
Authors:
ANDERSEN P
SELJEFLOT I
HERZOG A
ARNESEN H
HJERMANN I
HOLME I
Citation: P. Andersen et al., EFFECTS OF DOXAZOSIN AND ATENOLOL ON ATHEROTHROMBOGENIC RISK PROFILE IN HYPERTENSIVE MIDDLE-AGED MEN, Journal of cardiovascular pharmacology, 31(5), 1998, pp. 677-683
Authors:
ROSTRUP M
WESTHEIM A
REFSUM HE
HOLME I
EIDE I
Citation: M. Rostrup et al., ARTERIAL AND VENOUS PLASMA-CATECHOLAMINES DURING SUBMAXIMAL STEADY-STATE EXERCISE, Clinical physiology, 18(2), 1998, pp. 109-115
Authors:
JUNGNER I
MARCOVINA SM
WALLDIUS G
HOLME I
KOLAR W
STEINER E
Citation: I. Jungner et al., APOLIPOPROTEIN-B AND A-I VALUES IN 147,576 SWEDISH MALES AND FEMALES,STANDARDIZED ACCORDING TO THE WORLD-HEALTH-ORGANIZATION INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY FIRST INTERNATIONAL REFERENCE MATERIALS, Clinical chemistry, 44(8), 1998, pp. 1641-1649
Authors:
JUNGER I
MARCOVINA SM
WALLDIUS G
HOLME I
KOLAR W
STEINER S
Citation: I. Junger et al., APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-1 VALUES IN 147,576 SWEDISH MALES AND FEMALES STANDARDIZED ACCORDING TO THE WHO-IFCC INTERNATIONAL REFERENCE MATERIAL, Clinical chemistry, 44, 1998, pp. 358-358
Authors:
HOLDAAS H
HARTMANN A
LEIVESTAD T
FAUCHALD P
BREKKE IB
NORDAL KP
HOLME I
BERG KJ
Citation: H. Holdaas et al., MORTALITY OF LIVING KIDNEY DONORS DURING 32 YEARS OF OBSERVATION, Journal of the American Society of Nephrology, 8, 1997, pp. 3189-3189
Authors:
HOLME I
Citation: I. Holme, IMPROVED TARGETING OF PRIMARY PREVENTION AFTER WOSCOPS, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 7(5), 1997, pp. 344-351
Authors:
SORENSEN M
ANDERSSEN S
HJERMAN I
HOLME I
URSIN H
Citation: M. Sorensen et al., EXERCISE AND DIET INTERVENTIONS IMPROVE PERCEPTIONS OF SELF IN MIDDLE-AGED ADULTS, Scandinavian journal of medicine & science in sports, 7(5), 1997, pp. 312-320
Authors:
OTTERSTAD JE
FROELAND G
SUTTON MS
HOLME I
Citation: Je. Otterstad et al., ACCURACY AND REPRODUCIBILITY OF BIPLANE 2-DIMENSIONAL ECHOCARDIOGRAPHIC MEASUREMENTS OF LEFT-VENTRICULAR DIMENSIONS AND FUNCTION, European heart journal, 18(3), 1997, pp. 507-513
Authors:
TORJESEN PA
BIRKELAND KI
ANDERSSEN SA
HJERMANN I
HOLME I
URDAL P
Citation: Pa. Torjesen et al., LIFE-STYLE CHANGES MAY REVERSE DEVELOPMENT OF THE INSULIN-RESISTANCE SYNDROME - THE OSLO DIET AND EXERCISE STUDY - A RANDOMIZED TRIAL, Diabetes care, 20(1), 1997, pp. 26-31
Authors:
HAHEIM LL
HOLME I
HJERMANN I
LEREN P
Citation: Ll. Haheim et al., NONFASTING SERUM GLUCOSE AND THE RISK OF FATAL STROKE IN DIABETIC ANDNONDIABETIC SUBJECTS - 18-YEAR FOLLOW-UP OF THE OSLO STUDY (VOL 26, PG 774, 1995), Stroke, 28(5), 1997, pp. 1092-1092
Authors:
ERIKSSON M
HADELL K
HOLME I
WALLDIUS G
KJELLSTROM T
Citation: M. Eriksson et al., COMPLIANCE WITH AND EFFICACY OF TREATMENT WITH PRAVASTATIN AND CHOLESTYRAMINE - A RANDOMIZED STUDY ON LIPID-LOWERING IN PRIMARY-CARE, Atherosclerosis, 134(1-2), 1997, pp. 55-55
Authors:
HJERMANN I
HOLME I
ANDERSSEN SA
LOVFALD MK
Citation: I. Hjermann et al., HYPERTENSION HIGH-RISK MANAGEMENT TRIAL (HYRIM) - PREVENTION OF ATHEROSCLEROSIS AND LEFT-VENTRICULAR HYPERTROPHY DEVELOPMENT BY INTENSIVE LIFE-STYLE OR FLUVASTATIN TREATMENT IN HYPERTENSIVES, Atherosclerosis, 134(1-2), 1997, pp. 97-97
Authors:
ANDERSSEN SA
HJERMANN I
URDAL P
TORJESEN PA
HOLME I
Citation: Sa. Anderssen et al., IMPROVED CARBOHYDRATE-METABOLISM AFTER PHYSICAL-TRAINING AND DIETARY INTERVENTION IN INDIVIDUALS WITH THE ATHEROTHROMBOGENIC SYNDROME - OSLO DIET AND EXERCISE STUDY (ODES) - A RANDOMIZED TRIAL, Journal of internal medicine, 240(4), 1996, pp. 203-209
Authors:
MOLGAARD J
VONSCHENCK H
KUUSI T
HOLME I
LASSVIK C
TASKINEN MR
OLSSON AG
Citation: J. Molgaard et al., PLASMA-LIPOPROTEIN ABNORMALITIES AND APOLIPOPROTEIN-E PHENOTYPES IN INTERMITTENT CLAUDICATION - A MULTIVARIATE-ANALYSIS OF RANDOMLY SELECTED SUBJECTS, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 6(3), 1996, pp. 114-123
Authors:
LIAO DP
CAI JW
BARNES RW
TYROLER HA
RAUTAHARJU P
HOLME I
HEISS G
Citation: Dp. Liao et al., ASSOCIATION OF CARDIAC AUTONOMIC FUNCTION AND THE DEVELOPMENT OF HYPERTENSION - THE ARC STUDY, American journal of hypertension, 9(12), 1996, pp. 1147-1156
Authors:
GULLESTAD L
HALLEN J
MEDBO JI
GRONNEROD O
HOLME I
SEJERSTED OM
Citation: L. Gullestad et al., THE EFFECT OF ACUTE VS CHRONIC TREATMENT WITH BETA-ADRENOCEPTOR BLOCKADE ON EXERCISE PERFORMANCE, HEMODYNAMIC AND METABOLIC PARAMETERS IN HEALTHY-MEN AND WOMEN, British journal of clinical pharmacology, 41(1), 1996, pp. 57-67
Authors:
HOLME I
Citation: I. Holme, RELATIONSHIP BETWEEN TOTAL MORTALITY AND CHOLESTEROL REDUCTION AS FOUND BY META-REGRESSION ANALYSIS OF RANDOMIZED CHOLESTEROL-LOWERING TRIALS, Controlled clinical trials, 17(1), 1996, pp. 13-22
Authors:
HAHEIM LL
HOLME I
HJERMANN I
LEREN P
Citation: Ll. Haheim et al., SMOKING-HABITS AND RISK OF FATAL STROKE - 18 YEARS FOLLOW-UP OF THE OSLO STUDY, Journal of epidemiology and community health, 50(6), 1996, pp. 621-624
Authors:
REGNSTROM J
WALLDIUS G
NILSSON S
ELINDER LS
JOHANSSON J
MOLGAARD J
HOLME I
OLSSON AG
NILSSON J
Citation: J. Regnstrom et al., THE EFFECT OF PROBUCOL ON LOW-DENSITY-LIPOPROTEIN OXIDATION AND FEMORAL ATHEROSCLEROSIS, Atherosclerosis, 125(2), 1996, pp. 217-229
Authors:
HOLME I
URDAL P
ANDERSSEN S
HJERMANN I
Citation: I. Holme et al., EXERCISE-INDUCED INCREASE IN LIPOPROTEIN (A), Atherosclerosis, 122(1), 1996, pp. 97-104
Authors:
JOHANSSON J
OLSSON AG
BERGSTRAND L
ELINDER LS
NILSSON S
ERIKSON U
MOLGAARD J
HOLME I
WALLDIUS G
Citation: J. Johansson et al., LOWERING OF HDL(2B) BY PROBUCOL PARTLY EXPLAINS THE FAILURE OF THE DRUG TO AFFECT FEMORAL ATHEROSCLEROSIS IN SUBJECTS WITH HYPERCHOLESTEROLEMIA - A PROBUCOL QUANTITATIVE REGRESSION SWEDISH TRIAL (PQRST) REPORT, Arteriosclerosis, thrombosis, and vascular biology, 15(8), 1995, pp. 1049-1056
Authors:
ELINDER LS
HADELL K
JOHANSSON J
MOLGAARD J
HOLME I
OLSSON AG
WALLDIUS G
Citation: Ls. Elinder et al., PROBUCOL TREATMENT DECREASES SERUM CONCENTRATIONS OF DIET-DERIVED ANTIOXIDANTS, Arteriosclerosis, thrombosis, and vascular biology, 15(8), 1995, pp. 1057-1063
Authors:
BERNSTEIN R
MIDTBO K
SMITH G
MULLER C
HAUG E
HOLME I
HERTZENBERG L
Citation: R. Bernstein et al., INCIDENCE OF HYPERTROPHIC CARDIOMYOPATHY IN HYPOTHYROIDISM, Thyroid, 5(4), 1995, pp. 277-281